Blue Cross Blue Shield · Cartilage Restoration · US health-plan appeal rights

Cartilage Restoration denied due to quantity / dose limits by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield Cartilage Restoration denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-11

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for cartilage restoration are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: BCBS Specialty Surgery — MACI Autologous Chondrocyte Implantation

The Blue Cross Blue Shield angle on Cartilage Restoration

## Why BCBS Denied Cartilage Restoration for Quantity Limits

Blue Cross Blue Shield's medical policies for cartilage restoration procedures frequently include quantity or frequency restrictions — for example, limiting coverage to a single procedure per joint, a maximum number of treated defects per session, or a restriction on repeat procedures within a defined timeframe. When your surgeon's treatment plan exceeds those limits, the claim or authorization is denied for "quantity limits." These denials are often successfully overturned when the treating physician provides individualized clinical justification showing why the standard quantity restriction does not fit your specific anatomy or disease burden.

## Why This Denial Is Appealable

Quantity limits in medical policies are designed for typical cases. When your situation is atypical — for instance, multiple discrete lesions identified on imaging, a larger defect area than a standard case, or a revision scenario — your surgeon can document why your case falls outside the circumstances the limit was designed to address. Plans are required to apply an individualized medical-necessity analysis and cannot apply a blanket quantity rule without considering clinical facts.

## Federal Appeal Framework

Internal appeal: Under ERISA §503 or applicable state law, you are entitled to a full-and-fair internal review. File within the deadline stated in your denial letter.
External review: Under ACA §2719, after final internal denial you may request independent external review, typically within a four-month window.
Expedited review: Request expedited processing if delay would cause serious harm to your health or functional status.

## Documentation to Gather

Imaging with lesion mapping: MRI or arthroscopic reports that document the number, location, size, and grade of each discrete cartilage defect your surgeon proposes to treat.
Operative plan: Your surgeon's written treatment plan explaining why each lesion requires treatment and why treating them together (or in the proposed volume) is medically necessary.
Diagnosis confirmation: Pathology or radiology reports confirming the extent of cartilage involvement.
Prior-treatment history: Documentation of what prior interventions were attempted for each affected area and why they were insufficient.
Medical-necessity letter: A detailed letter from your orthopedic surgeon addressing the quantity restriction specifically — acknowledging the plan's standard limit, explaining your clinical deviation from a typical case, and citing the applicable orthopaedic society guideline supporting treatment of multiple lesions when present.

## Criteria-Mapping Structure

Request a copy of BCBS's current medical policy for cartilage restoration, including the quantity-limit provision and any exception criteria. Build a criteria table: left column lists each policy requirement and each quantity limit; right column cites the specific imaging finding, operative note, or chart fact that justifies exceeding the limit. Make the table the centerpiece of your appeal letter so the reviewer can trace each justification to its source document without having to search through a large record submission.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other denial reasons for Blue Cross Blue Shield Cartilage Restoration

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-11. Editorial standards: denialhelp.com/authors.